Middlemen sue to block a signature Trump drug pricing proposal

Stat News

12 January 2021 - The Pharmaceutical Care Management Association, which represents drug middlemen in Washington, filed a lawsuit Tuesday to block implementation of one of President Trump’s signature drug pricing policies.

The policy at issue would prevent drug makers and middlemen from negotiating rebates on prescription drugs.

Read Stat News article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing